Sequence Inc. is a **biopharmaceutical** consulting company committed to enhancing the quality of life through advancements in the life sciences industry. Established in **2002**, the company offers a wide range of consultancy services, specializing in Commissioning, Qualification, and Validation (CQV), as well as digital solutions for facilities, utilities, equipment, computerized systems, and labs. The organization stands out with its fully operational mock pharmaceutical manufacturing training facility, providing consultants with a distinctive hands-on learning experience encompassing equipment and software. **Sequence Inc.** caters to clients throughout the U.S. and parts of Europe, with its main office situated in the thriving tech hub of RTP in **Morrisville, NC**, and a secondary hub in **Framingham, MA**. Notably, the company has not disclosed its latest investment details or participating investors. With its impressive track record and a focus on a rapidly evolving industry, **Sequence Inc.** presents an intriguing opportunity for potential venture capital investments.
There is no investment information
No recent news or press coverage available for Sequence Inc..